These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10086453)

  • 1. Cutaneous manifestations of biological warfare and related threat agents.
    McGovern TW; Christopher GW; Eitzen EM
    Arch Dermatol; 1999 Mar; 135(3):311-22. PubMed ID: 10086453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations of category A bioweapons.
    Aquino LL; Wu JJ
    J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological warfare and the skin I: bacteria and toxins.
    Cieslak TJ; Talbot TB; Hartstein BH
    Clin Dermatol; 2002; 20(4):346-54. PubMed ID: 12208622
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous reactions in nuclear, biological and chemical warfare.
    Arora S
    Indian J Dermatol Venereol Leprol; 2005; 71(2):80-6. PubMed ID: 16394378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical recognition and management of patients exposed to biological warfare agents.
    Franz DR; Jahrling PB; Friedlander AM; McClain DJ; Hoover DL; Bryne WR; Pavlin JA; Christopher GW; Eitzen EM
    JAMA; 1997 Aug; 278(5):399-411. PubMed ID: 9244332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The threat of biological terrorism: a public health and infection control reality.
    Leggiadro RJ
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1):53-6. PubMed ID: 10656359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial agents used for bioterrorism.
    Horn JK
    Surg Infect (Larchmt); 2003; 4(3):281-7. PubMed ID: 14588163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the prevention of a successful biological warfare aerosol attack.
    Wiener SL
    Mil Med; 1996 May; 161(5):251-6. PubMed ID: 8855053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical aspects of bio-terrorism.
    Balali-Mood M; Moshiri M; Etemad L
    Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dermatological aspects in the risk of biological warfare].
    Carsuzaa F; Boyé T; Debord T; Guennoc B; Fournier B; Cavallo JD
    Presse Med; 2005 Jan; 34(2 Pt 2):189-92. PubMed ID: 15687970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological warfare from a dermatologic perspective.
    Meffert JJ
    Curr Allergy Asthma Rep; 2003 Jul; 3(4):304-10. PubMed ID: 12791207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and vaccines against biological weapons.
    Conn Med; 2001 Dec; 65(12):719-20. PubMed ID: 11797482
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hemorrhagic fever as a biological weapon].
    Robenshtok E; Laster M; Katz L; Brenner B; Sagi R
    Harefuah; 2002 May; 141 Spec No():96-9, 119. PubMed ID: 12170564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Being prepared: bioterrorism and mass prophylaxis: part II.
    Weant KA; Bailey AM; Fleishaker EL; Justice SB
    Adv Emerg Nurs J; 2014; 36(4):307-17; quiz 318-9. PubMed ID: 25356890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological warfare. I. Anthrax, plague, tularemia].
    Christ W; Stein H
    Med Monatsschr Pharm; 2002 Dec; 25(12):406-17. PubMed ID: 12522911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 19. Confronting bioterrorism: physicians on the front line.
    Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT
    Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.
    Funk EA
    Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.